1. Home
  2. LUNG vs GECC Comparison

LUNG vs GECC Comparison

Compare LUNG & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • GECC
  • Stock Information
  • Founded
  • LUNG 1995
  • GECC 2016
  • Country
  • LUNG United States
  • GECC United States
  • Employees
  • LUNG N/A
  • GECC N/A
  • Industry
  • LUNG Industrial Specialties
  • GECC Finance: Consumer Services
  • Sector
  • LUNG Health Care
  • GECC Finance
  • Exchange
  • LUNG Nasdaq
  • GECC Nasdaq
  • Market Cap
  • LUNG 124.0M
  • GECC 122.4M
  • IPO Year
  • LUNG 2020
  • GECC N/A
  • Fundamental
  • Price
  • LUNG $2.67
  • GECC $10.50
  • Analyst Decision
  • LUNG Buy
  • GECC
  • Analyst Count
  • LUNG 6
  • GECC 0
  • Target Price
  • LUNG $11.53
  • GECC N/A
  • AVG Volume (30 Days)
  • LUNG 366.5K
  • GECC 20.2K
  • Earning Date
  • LUNG 07-30-2025
  • GECC 07-31-2025
  • Dividend Yield
  • LUNG N/A
  • GECC 14.07%
  • EPS Growth
  • LUNG N/A
  • GECC N/A
  • EPS
  • LUNG N/A
  • GECC 0.42
  • Revenue
  • LUNG $87,473,000.00
  • GECC $42,909,000.00
  • Revenue This Year
  • LUNG $18.02
  • GECC $32.54
  • Revenue Next Year
  • LUNG $18.17
  • GECC N/A
  • P/E Ratio
  • LUNG N/A
  • GECC $25.06
  • Revenue Growth
  • LUNG 19.84
  • GECC 18.13
  • 52 Week Low
  • LUNG $2.62
  • GECC $8.87
  • 52 Week High
  • LUNG $9.37
  • GECC $11.39
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 33.53
  • GECC 46.09
  • Support Level
  • LUNG $2.62
  • GECC $10.90
  • Resistance Level
  • LUNG $3.52
  • GECC $10.62
  • Average True Range (ATR)
  • LUNG 0.23
  • GECC 0.22
  • MACD
  • LUNG 0.02
  • GECC -0.06
  • Stochastic Oscillator
  • LUNG 13.46
  • GECC 25.53

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.

Share on Social Networks: